Skip to main content
Andrew Himelstein, MD, Oncology, Newark, DE, St. Francis Hospital

AndrewLHimelsteinMD

Oncology • Newark, DE

Assistant Clinical Professor of Medicine, Thomas Jefferson University

Join to view full profile

Are you Dr. Himelstein?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 81 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Andrew Himelstein, MD is an oncologist in Newark, Delaware. He is currently licensed to practice medicine in Delaware, New Jersey, and Pennsylvania. He is affiliated with ChristianaCare and St. Francis Hospital.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 1988 - 1991
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1985 - 1988
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1985

Certifications & Licensure

  • DE State Medical License
    DE State Medical License 1991 - 2025
  • PA State Medical License
    PA State Medical License 1991 - 2024
  • NJ State Medical License
    NJ State Medical License 1991 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Fellow (FACP) American College of Physicians, 1998

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • COMMENTARY: Start the Conversation with Your Doctor
    COMMENTARY: Start the Conversation with Your DoctorFebruary 17th, 2019
  • Less Frequent Zoledronic Acid Not Linked to Increased Skeletal Events for Patients with Bone Metastases
    Less Frequent Zoledronic Acid Not Linked to Increased Skeletal Events for Patients with Bone MetastasesJanuary 8th, 2017
  • Powerful Drug for Advanced Cancers May Need Less Frequent Dosing
    Powerful Drug for Advanced Cancers May Need Less Frequent DosingJanuary 4th, 2017

Professional Memberships

Hospital Affiliations

Dr. Andrew Himelstein, Dr. Andrew Himelstein, MD, Dr. A Himelstein, Dr. Andrew L Himelstein